Supreme Court weighs FDA block on kid-friendly flavored vapes
With e-cigarette sales booming, the Supreme Court will decide whether the FDA unlawfully blocked approval of more than a ...
Pie Recall Update As FDA Sets Most Serious Risk Level
Products sold in the Northwest have been given the highest risk status, but so far no illnesses have been reported.
CDC, FDA probe tainted cucumbers that sickened 68 people in 19 states
Federal and state health officials said Friday they are working to track down more information about a Salmonella outbreak ...
Trump’s former FDA commissioner warns RFK Jr. could ‘cost lives’ if confirmed
Scott Gottlieb said he’s worried that Trump’s pick to run HHS, Robert F. Kennedy Jr., will follow through on past antivaccine ...
Ex-FDA Commissioner Says RFK Jr. 'Will Cost Lives' As Head Of Health Department
Scott Gottlieb, who served early on in Trump's first term, is now warning senators about the impact Kennedy could have on ...
FDA leader during Trump’s first term sounds alarm on RFK Jr’s potential plans: ‘It will cost lives’
Trump administration pick for Health and Human Services department could cause rise in preventable disease, health expert ...
Medpage Today on MSN2d
Florida's Canadian Drug Import Plan Goes Nowhere After FDA Approval
Ron DeSantis hailed the FDA's approval of his plan in January, calling it a victory over the drug industry, which opposes ...
PBS3d
Why the FDA wants to pull this common cold medicine ingredient from shelves
With winter setting in around much of the country, many people are also gearing up for cough and cold season. But the Food ...
Vivek Ramaswamy’s crusade to change FDA could boost biotech, and himself
The co-leader of President-elect Donald Trump’s initiative to cut government spending has a financial stake in the biotech ...
FDA defeats lawsuit by lawyer vying to shield identity in inspection report
A judge has dismissed a lawsuit against the U.S. Food and Drug Administration by a lawyer who objected to being identified in ...
FDA probes blood cancer risk from bluebird's gene therapy, weighs regulatory action
The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...